Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew H Ko

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
Journal of Surgical Oncology|July 23, 2016
Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy?Sunhee S Kim, Eric K Nakakura, Zhen J Wang, et al.
Journal of Surgical Oncology|August 30, 2016
Hybrid minimally invasive Ivor Lewis esophagectomy after neoadjuvant chemoradiation yields excellent long-term survival outcomes with minimal morbidityGavitt A Woodard, Jane C Crockard, Carolyn Clary-Macy, et al.
Pancreas|May 13, 2016
Oxaliplatin-Fluoropyrimidine Chemotherapy Plus Bevacizumab in Advanced Neuroendocrine Tumors: An Analysis of 2 Phase II TrialsPamela L Kunz, Raymond R Balise, Louis Fehrenbacher, et al.
Pancreas|October 7, 2022
Helping Patients Understand Pancreatic Cancer Using Animated Pancreas Patient Education With Visual Formats of LearningSatish Munigala, Timothy B Gardner, Eileen M O'Reilly, et al.
American Journal of Clinical Oncology|May 10, 2011
Optimizing the administration of fixed-dose rate gemcitabine plus capecitabine using an alternating-week schedule: a dose finding and early efficacy study in advanced pancreatic and biliary carcinomasAndrew H Ko, Anne M Espinoza, Kimberly A Jones, et al.
Pancreas|September 22, 2015
A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic AdenocarcinomaAndrew H Ko, Noelle LoConte, Margaret A Tempero, et al.
Investigational New Drugs|March 5, 2024
A multicenter phase Ia study of AbGn-107, a novel antibody-drug conjugate, in patients with advanced gastrointestinal cancerAndrew H Ko, Andrew L Coveler, Benjamin L Schlechter, et al.
Physical Biology|February 7, 2012
Characterization of circulating tumor cell aggregates identified in patients with epithelial tumorsEdward H Cho, Marco Wendel, Madelyn Luttgen, et al.
Pancreas|October 5, 2018
Understanding Pancreatic Diseases Using Animated Pancreas Patient: Informing Patients for Better Health Outcomes With Visual Formats of LearningSatish Munigala, Timothy B Gardner, Eileen M OʼReilly, et al.
JCO Precision Oncology|June 12, 2024
Synthetic Lethality Beyond BRCA: A Phase I Study of Rucaparib and Irinotecan in Metastatic Solid Tumors With Homologous Recombination-Deficiency Mutations Beyond BRCA1/2Erica S Tsang, Mallika S Dhawan, Romain Pacaud, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Journal of Surgical Oncology|July 23, 2016
Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy?Sunhee S Kim, Eric K Nakakura, Zhen J Wang, et al.
Journal of Surgical Oncology|August 30, 2016
Hybrid minimally invasive Ivor Lewis esophagectomy after neoadjuvant chemoradiation yields excellent long-term survival outcomes with minimal morbidityGavitt A Woodard, Jane C Crockard, Carolyn Clary-Macy, et al.
Pancreas|May 13, 2016
Oxaliplatin-Fluoropyrimidine Chemotherapy Plus Bevacizumab in Advanced Neuroendocrine Tumors: An Analysis of 2 Phase II TrialsPamela L Kunz, Raymond R Balise, Louis Fehrenbacher, et al.
Pancreas|October 7, 2022
Helping Patients Understand Pancreatic Cancer Using Animated Pancreas Patient Education With Visual Formats of LearningSatish Munigala, Timothy B Gardner, Eileen M O'Reilly, et al.
American Journal of Clinical Oncology|May 10, 2011
Optimizing the administration of fixed-dose rate gemcitabine plus capecitabine using an alternating-week schedule: a dose finding and early efficacy study in advanced pancreatic and biliary carcinomasAndrew H Ko, Anne M Espinoza, Kimberly A Jones, et al.
Pancreas|September 22, 2015
A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic AdenocarcinomaAndrew H Ko, Noelle LoConte, Margaret A Tempero, et al.
Investigational New Drugs|March 5, 2024
A multicenter phase Ia study of AbGn-107, a novel antibody-drug conjugate, in patients with advanced gastrointestinal cancerAndrew H Ko, Andrew L Coveler, Benjamin L Schlechter, et al.
Physical Biology|February 7, 2012
Characterization of circulating tumor cell aggregates identified in patients with epithelial tumorsEdward H Cho, Marco Wendel, Madelyn Luttgen, et al.
Pancreas|October 5, 2018
Understanding Pancreatic Diseases Using Animated Pancreas Patient: Informing Patients for Better Health Outcomes With Visual Formats of LearningSatish Munigala, Timothy B Gardner, Eileen M OʼReilly, et al.
JCO Precision Oncology|June 12, 2024
Synthetic Lethality Beyond BRCA: A Phase I Study of Rucaparib and Irinotecan in Metastatic Solid Tumors With Homologous Recombination-Deficiency Mutations Beyond BRCA1/2Erica S Tsang, Mallika S Dhawan, Romain Pacaud, et al.
Pageof 10